Developing an EQ-5D-5L Value Set for Singapore
PharmacoEconomics · 2025-12 · 43 (12) · 1419-1431
DOI: 10.1007/s40273-025-01519-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift PharmacoEconomics, online erschienen am 29.08.2025. Verfasst von Nan Luo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore. ephln@nus.edu.sg. Hauptthemen laut MEDLINE: Quality of Life, Health Status, Technology Assessment, Biomedical. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation Singapore, EuroQol Research Foundation.
Abstract (Originalsprache)
OBJECTIVES: The EQ-5D-5L is a multi-attribute utility instrument recommended by many health technology assessment agencies. This study aimed to develop an EQ-5D-5L value set for Singapore. METHODS: A 'lite' version of the EuroQol Research Foundation's EQ-5D-5L valuation protocol, which was designed to value a total of 91 health states using a composite time trade-off (cTTO) method, was followed. Five hundred members of the general public in Singapore were quota-sampled and invited to a personal interview face-to-face or via Zoom. All participants completed 20 cTTO tasks administered using the EuroQol Valuation Technology (EQ-VT) program. Cross-validation analysis was performed to identify the best-performing model for estimating the values of all the 3,125 EQ-5D-5L health states. RESULTS: A 20-parameter main-effects model with two two-way interaction terms outperformed other models in the cross-validation analysis. The value set estimated using this model ranges from - 0.851 (for state 55555) to 1.000 (for state 11111), with pain/discomfort and anxiety/depression dimensions associated with the greatest disutility. CONCLUSIONS: We developed an EQ-5D-5L value set based on the health preferences of Singaporeans. We recommend EQ-5D-5L users in Singapore to use this value set and encourage a more systematic and dedicated methodological effort to understand interaction effects and potential non-linearities in the valuation of multi-attribute health descriptive systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore. ephln@nus.edu.sg.
- School of Pharmacy, Faculty of Health and Medical Sciences, Taylor's University, Subang Jaya, Selangor, Malaysia.
- Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.
- National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
- Alice Lee Centre for Nursing Studies, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Health Services Management Department, Guizhou Medical University, Guiyang, People's Republic of China.
ORCID-Profile: Nan Luo, Annushiah Vasan Thakumar, Ling Jie Cheng, Zhihao Yang, Kim Rand, Yin Bun Cheung, Julian Thumboo
Förderung
- National Research Foundation Singapore
- EuroQol Research Foundation
Zitieren
APA
Luo, N., Vasan Thakumar, A., Cheng, L. J., Yang, Z., Rand, K., Cheung, Y. B., & Thumboo, J. (2025). Developing an EQ-5D-5L Value Set for Singapore. PharmacoEconomics, 43(12), 1419-1431. https://doi.org/10.1007/s40273-025-01519-7
Vancouver
Luo N, Vasan Thakumar A, Cheng LJ, Yang Z, Rand K, Cheung YB, et al. Developing an EQ-5D-5L Value Set for Singapore. PharmacoEconomics. 2025;43(12):1419-1431. doi:10.1007/s40273-025-01519-7
BibTeX
@article{Luo2025,
author = {Luo, Nan and Vasan Thakumar, Annushiah and Cheng, Ling Jie and Yang, Zhihao and Rand, Kim and Cheung, Yin Bun and Thumboo, Julian},
title = {Developing an EQ-5D-5L Value Set for Singapore},
journal = {PharmacoEconomics},
year = {2025},
volume = {43},
number = {12},
pages = {1419--1431},
doi = {10.1007/s40273-025-01519-7}
}
EUVIMED